Clinical Trial Update: The Effect of Ranibizumab on Eye Lens Opacity in Cases With Age-Related Macular Degeneration

View source ↗

Summary

This completed clinical trial evaluated whether ranibizumab affects eye lens opacity (cataract) in patients with age-related macular degeneration. The sponsor i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Cataract

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Uludag University | Conditions: Age-Related Macular Degeneration, Cataract | Status: COMPLETED